Veru expands oncology drug pipeline; exclusively licenses phase 3 clinical stage targeted therapy for endocrine resistant metastatic breast cancer

-- transformation to p remium o ncology b iopharmaceutical c ompany with l ate - s tage clinical drug p ipeline f ocused on p rostate and b reast c ancer is c omplete -- -- company poised to initiate four oncology drug registration trials i n prostate and breast cancer in calendar year 2021 --
VERU Ratings Summary
VERU Quant Ranking